Sajith Wickramasekara’s Post

View profile for Sajith Wickramasekara, graphic

Founder & CEO at Benchling

One of the most fun chats (literally) I've recently had. Thanks for having me Andrew Dunn and for the introvert friendly medium.

View profile for Andrew Dunn, graphic
Andrew Dunn Andrew Dunn is an Influencer

Senior Biopharma Correspondent at Endpoints News

NEW: I invited Benchling CEO Sajith Wickramasekara to join our secret Slack channel to discuss the latest on the biotech market, his startup, and some hot takes on AI in the life sciences. "Current course and speed, I think the billions in AI funding leads to the same number of new medicines approved each year 😬" Wickramasekara wrote, saying that so much AI attention is on "designing molecules but there’s so much toil in making medicines outside of that." My latest for Endpoints News with the latest Slack chat:

The Endpoints Slack interview: Saji Wickramasekara on where AI misses the mark — and what’s next for Benchling

The Endpoints Slack interview: Saji Wickramasekara on where AI misses the mark — and what’s next for Benchling

https://endpts.com

Zakaria Mahmud (Hiring)

★Technical Agile Lead @GSK | Hiring on synergysearch.net | Cofounder | Aspiring young minds

3w

This is awesome Sajith Wickramasekara. Keep up the great work.

Like
Reply

To view or add a comment, sign in

Explore topics